DOCK2 and breast cancer: Of the 15 validated biomarkers, the lncRNA GVINP1 and five mRNAs (CCDC69, DOCK2, IKZF1, JCHAIN, and NCKAP1L) had not been previously reported in BC, but these independent factors might serve as prognostic biomarkers.